The U.S. Federal Trade Commission (FTC) has approved Abbott Laboratories' $25 billion acquisition of St. Jude Medical Inc. The deal was green lit after the FTC accepted a proposal for the divestiture of St. Jude's vascular closure device business and Abbott's steerable sheath business to Terumo Corp. Read More
